跳至主要内容
临床试验/ACTRN12619000688189
ACTRN12619000688189尚未招募未知

Comparison of microfracture and Autologous Bio-scaffold Enhanced Chondrogenesis (ABEC) in treatment of osteochondral lesions of the talus: A prospective, randomized study (MALT)

Capital and Coast District Health Board (CCDHB)0 个研究点目标入组 170 人开始时间: 2019年5月7日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Symptomatic osteochondral lesion of the talus where microfracture has been offered, with at least 6 months of non-surgical management, as confirmed on MRI, in patients with skeletally mature ankles, aged 18 to 60 years old.
  • Able to consent to trial inclusion
  • Medically fit for surgery

排除标准

  • Lesions too small to be considered for microfracture or a specific contra-indication to microfracture
  • Declared intolerance or allergy to crustaceans or D-glucosamine
  • Bipolar lesions (kissing lesions of the tibial plafond and talus)
  • Diffuse arthritic changes
  • Previous ankle operation
  • Neuromuscular disorders
  • Metabolic arthropathy
  • Active infection
  • Self-funded surgery

研究者

发起方
Capital and Coast District Health Board (CCDHB)

相似试验